The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Suria Hamza since 2018.
This trader's CIK number is 1654495.
At the time of last reporting, Suria Hamza was the President, CEO of Anaptysbio, Inc. (stock ticker symbol ANAB).
Also see all insider trading activities at Anaptysbio, Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | ANAB | 0 | $0 | 109,645 | $3,693,808 | 119,645 | $134,001 |
| 2020 | ANAB | 0 | $0 | 0 | $0 | 20,000 | $22,400 |
| 2019 | ANAB | 0 | $0 | 62,428 | $4,509,065 | 60,000 | $67,200 |
| 2018 | ANAB | 0 | $0 | 107,313 | $7,608,584 | 132,379 | $187,379 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-12-20 | ANAB | Option Ex | 36,645 | 1.12 | 41,042 |
| 2021-12-20 | ANAB | Sale | 36,645 | 35.68 | 1,307,640 |
| 2021-11-04 | ANAB | Option Ex | 6,059 | 1.12 | 6,786 |
| 2021-11-05 | ANAB | Option Ex | 14,302 | 1.12 | 16,018 |
| 2021-11-04 | ANAB | Sale | 6,059 | 35.00 | 212,065 |
| 2021-11-05 | ANAB | Sale | 14,302 | 35.00 | 500,570 |
| 2021-11-01 | ANAB | Option Ex | 36,646 | 1.12 | 41,043 |
| 2021-11-01 | ANAB | Sale | 36,646 | 32.58 | 1,193,743 |
| 2021-10-26 | ANAB | Option Ex | 15,993 | 1.12 | 17,912 |
| 2021-10-26 | ANAB | Sale | 15,993 | 30.00 | 479,790 |
| 2021-09-17 | ANAB | Option Ex | 10,000 | 1.12 | 11,200 |
| 2020-03-10 | ANAB | Option Ex | 10,000 | 1.12 | 11,200 |
| 2020-02-05 | ANAB | Option Ex | 10,000 | 1.12 | 11,200 |
| 2019-11-22 | ANAB | Option Ex | 10,000 | 1.12 | 11,200 |
| 2019-06-10 | ANAB | Sale | 22,428 | 74.64 | 1,674,025 |
| 2019-04-17 | ANAB | Option Ex | 10,000 | 1.12 | 11,200 |
| 2019-01-14 | ANAB | Option Ex | 40,000 | 1.12 | 44,800 |
| 2019-01-14 | ANAB | Sale | 40,000 | 70.88 | 2,835,040 |
| 2018-12-14 | ANAB | Option Ex | 41,728 | 1.12 | 46,735 |
| 2018-12-14 | ANAB | Sale | 41,728 | 69.69 | 2,908,107 |
| 2018-12-12 | ANAB | Sale | 30,000 | 71.97 | 2,159,040 |
| 2018-12-11 | ANAB | Sale | 4,998 | 70.83 | 354,008 |
| 2018-12-12 | ANAB | Option Ex | 30,000 | 1.12 | 33,600 |
| 2018-12-10 | ANAB | Sale | 30,587 | 71.52 | 2,187,429 |
| 2018-12-10 | ANAB | Option Ex | 30,587 | 1.12 | 34,257 |
| 2018-07-09 | ANAB | Option Ex | 7,636 | 1.93 | 14,699 |
| 2018-06-08 | ANAB | Option Ex | 22,428 | 2.59 | 58,088 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Suria Hamza (President, CEO of Anaptysbio, Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.